Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia-Reference-Cited by-同舟云学术

Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia

Published:2011-09-21 Issue:1 Volume:11 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Aljunid Syed,Abuduxike Gulifeiya,Ahmed Zafar,Sulong Saperi,Nur Amrizal Muhd,Goh Adrian

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/article/10.1186/1471-2334-11-248/fulltext.html

Reference41 articles.

1. Hausdorff WP, Bryant J, Paradiso PR, Siber GR: Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000, 30: 100-121. 10.1086/313608.

2. Isaacman DJ, McIntosh ED, Reinert RR: Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010, 14: e197-209.

3. Lin TY, Shah NK, Brooks D, Garcia CS: Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region. Vaccine. 2010, 28: 7589-7605. 10.1016/j.vaccine.2010.07.053.

4. Gil-Prieto R, García-García L, Alvaro-Meca A, Méndez C, García A, de Miguel AG: The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007). Vaccine. 2011, 412-416. 29

5. Centers for Disease Control and Prevention: Epidemiology and Prevention of Vaccine-Preventable Diseases. 2011, Washington DC: Public Health Foundation, 12

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective database analysis for clinical diagnoses commonly associated with pneumococcal diseases in the Malaysian healthcare system over a 3-year period (2013–2015);BMC Infectious Diseases;2024-01-12

2. A brief history of and future prospects for pneumococcal vaccination in Malaysia;Pneumonia;2023-08-25

3. Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt;Human Vaccines & Immunotherapeutics;2022-09-07

4. Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysis;Pneumonia;2021-05-25

5. Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses;PharmacoEconomics - Open;2021-05-04